Emerging From the Haze for Gynecologic Cancer Survivors
| Status: | Completed | 
|---|---|
| Conditions: | Cervical Cancer, Cognitive Studies | 
| Therapuetic Areas: | Oncology, Psychiatry / Psychology | 
| Healthy: | No | 
| Age Range: | 18 - Any | 
| Updated: | 1/6/2019 | 
| Start Date: | January 10, 2017 | 
| End Date: | November 2017 | 
A Pilot Study of Emerging From the Haze Evaluating a Trainee-taught Psycho-educational Program to Improve Cancer-related Cognitive Complaints in Gynecologic Cancer Survivors
At Cedars-Sinai Medical Center, the investigators have developed a novel curriculum for a
6-week psycho-educationally-based, cognitive behavioral program to help patients with
subjective cognitive complaints after cancer treatment, titled Emerging from the Haze™
(Haze). Each series meets once a week for 2-2.5 hours for 6 weeks.
The objective of this study is to quantify the impact of a trainee-taught Emerging from the
Haze course on gynecologic cancer survivors' self-report of cognitive changes based on the
change of FACT-Cog score.
			6-week psycho-educationally-based, cognitive behavioral program to help patients with
subjective cognitive complaints after cancer treatment, titled Emerging from the Haze™
(Haze). Each series meets once a week for 2-2.5 hours for 6 weeks.
The objective of this study is to quantify the impact of a trainee-taught Emerging from the
Haze course on gynecologic cancer survivors' self-report of cognitive changes based on the
change of FACT-Cog score.
Inclusion Criteria:
- Diagnosis of any stage gynecologic cancer including ovarian, uterine/endometrial,
cervical, vulvar, and vaginal cancer
- Treated with chemotherapy solely or in combination with surgery, radiation, and/or
hormonal therapy
- Female, age ≥ 18 years.
- FACT-Cog score < 59 on the PCI sub scale
- Eligible after 2 months (60 ±5 days) of completing all their active cancer treatment
with the exception of long-term hormonal treatments
- Subjective complaint of cognitive concerns at time of enrollment
- Must be able to understand and communicate proficiently in English
- Ability to understand and the willingness to sign a written informed consent.
- Agree to complete study surveys
Exclusion Criteria:
- Patients who have significant personality disorders or unstable psychiatric disorders
(including active major depression, substance abuse, psychosis or bipolar disorder) as
assessed by the interviewing clinician
- Patients with known brain metastases, history of brain metastases or radiation to the
brain.
- Patients with a history of stroke or other pre-existing neurological condition that
may contribute to cognitive dysfunction.
- Non-English speakers
- Receiving treatment for another malignancy other than breast cancer
- Uncontrolled intercurrent illness including, but not limited to, ongoing or active
infection, chronic anemia, uncontrolled hypothyroidism, symptomatic congestive heart
failure, unstable angina pectoris, uncontrolled cardiac arrhythmia, or psychiatric
illness/social situations that would limit compliance with study requirements.
We found this trial at
    1
    site
	
		Cedars Sinai Med Ctr Cedars-Sinai is known for providing the highest quality patient care. Our...  
  
  Click here to add this to my saved trials